India resurgence fund in talks to acquire Ind-Swift's API businessEarlier in July 2021, Ind-Swift Laboratories had agreed to sell its API business to PI Industries on a slump sale basis, for ₹1,530 crore. ...
21 Jul, 2023, 02.06 AM IST
Alembic gets USFDA approval to market Clarithromycin tablets in AmericaAlembic's product is therapeutically equivalent to AbbVie Inc's Biaxin Filmtab Tablets, which is antimicrobial indicated to treat mild to m...
01 Feb, 2022, 01.48 PM IST
Lancet study finds no benefit for hydroxychloroquine in COVID-19 patientsThe scientists said these drugs should not be used to treat COVID-19 patients outside of clinical trials until results from randomised clin...
22 May, 2020, 07.31 PM IST
Teva-Allergan deal may divest products worth $600 millionAs Israeli drugmaker Teva readies to acquire Allergan as part of its recent $40.5-billion deal, a large bounty of products is expected to b...
27 Aug, 2015, 04.00 AM IST
Wockhardt recalls over 50 lakh bottles of various drugs in USAs per the information available on the USFDA, Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
03 Aug, 2015, 05.27 PM IST
Wockhardt recalls over 1.62 lakh cartons of drugs in USs per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for...
16 Jul, 2015, 06.37 PM IST
Sensex falls over 150 points, Sun TV plunges 28%, Eros gains 20%; top betsThe S&P BSE Sensex opened the day at 26,810.98, up 42.49 points. The broader 50-share Nifty opened the session at 8,114.7, down 15.95 point...
08 Jun, 2015, 11.27 AM IST
Twelve stocks in focus in Monday's tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.
08 Jun, 2015, 07.59 AM IST
Two drugs manufactured by Wockhardt recalled in the USAccording to information on the US Food and Drug Administration (USFDA) website, 166 bottles of Captopril tablets of 50 mg strength are bei...
05 Jun, 2015, 08.43 PM IST
- Ind Swift get USFDA nod for five active pharmaceutical ingredients
Ind Swift Laboratories today said it has received US health regulator's approval to sell five active pharmaceutical ingredients.
10 Apr, 2012, 05.55 PM IST
- Ind Swift Lab gets Australia's nod for its Dera Bassi plant
Drug firm Ind Swift said it has received approval from the Australian health regulator to make seven active pharmaceutical ingredients.
23 Sep, 2011, 08.27 PM IST
- US FDA blocks imports from Ranbaxy for poor quality
FDA move does not end US sales by Ranbaxy. The factories with defects are in Dewas and Paonta Sahib. The Top 10 food myths revealed | Bewar...
17 Sep, 2008, 06.33 AM IST
- Ranbaxy faces adulteration charges in US
US department of justice has said there was evidence to suggest that Ranbaxy used active pharmaceutical ingredients from unapproved sources...
14 Jul, 2008, 12.34 AM IST
- Pharma cos set sights on Japan
As pricing pressure intensifies in the US generics market, Indian pharma majors are planning rapid inroads into Japan, which is the worlds ...
02 Nov, 2007, 04.38 AM IST
- Ranbaxy recieves US approval for anti-bacterial drug
US Food and Drug Administration's has given the approval to manufacture and market anti-bacterial drug oral Clarithromycin in multiple stre...
05 Oct, 2007, 04.00 PM IST
- Ranbaxy gets USFDA nod for Clarithromycin oral suspension
Ranbaxy Laboratories has received final approval from the US Food and Drug Administration to manufacture and market Clarithromycin for oral...
04 Oct, 2007, 01.05 PM IST
- Ranbaxy gets FDA nod for clarithromycin
Ranbaxy is the first company to have been granted a generic approval for the oral suspension form along with clarithromycin tablets.
02 Oct, 2007, 07.50 PM IST